Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9131)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 28, 2017 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lew D, Yoon SM, Yan X, Robbins L, Haritunians T, Liu Z, Li D, McGovern DP. Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patients. World J Gastroenterol 2017; 23(40): 7265-7273 [PMID: 29142473 DOI: 10.3748/wjg.v23.i40.7265] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i40/7265.htm |
| Number | Citing Articles |
| 1 |
Dalin Li, Talin Haritunians, Carol Landers, Alka A Potdar, Shaohong Yang, Hailiang Huang, L Philip Schumm, Mark Daly, Stephan R Targan, Dermot P B McGovern. Late-Onset Crohn’s Disease Is A Subgroup Distinct in Genetic and Behavioral Risk Factors With UC-Like Characteristics. Inflammatory Bowel Diseases 2018; 24(11): 2413 doi: 10.1093/ibd/izy148
|
| 2 |
Maya Zvuloni, Manar Matar, Rachel Levi, Dror S. Shouval, Raanan Shamir, Amit Assa. High anti‐TNFα Concentrations Are Not Associated With More Adverse Events in Pediatric Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 2021; 73(6): 717 doi: 10.1097/MPG.0000000000003240
|
| 3 |
Cong Dai, Yi-nuo Wang, Wen-ning Tian, Yu-Hong Huang, Min Jiang. The incidence, clinical characteristics and serological characteristics of anti-tumor necrosis factor-induced lupus in patients with inflammatory bowel disease: A systematic review and meta-analysis. International Immunopharmacology 2022; 112: 109269 doi: 10.1016/j.intimp.2022.109269
|
| 4 |
Ruize Liu, Dalin Li, Talin Haritunians, Yunfeng Ruan, Mark J. Daly, Hailiang Huang, Dermot P.B. McGovern. Profiling the inflammatory bowel diseases using genetics, serum biomarkers, and smoking information. iScience 2023; 26(10): 108053 doi: 10.1016/j.isci.2023.108053
|